Sort by
Refine Your Search
-
student in data-driven precision medicine and diagnostics. This covers data integration, analysis, visualisation, and data interpretation. The project The industrial PhD student will develop a comprehensive
-
Sweden. In situ sequencing (ISS) enables highly multiplexed RNA profiling directly within cells and whole tissue sections, preserving spatial information for advanced molecular analysis. The facility’s
-
structural biolo’gy platform (https://www.scilifelab.se/services/integrated-structural-bioloqy). The unit provides access to cutting-edge equipment and expertise, for the analysis of protein interactions and
-
of reference genomes, annotation, and characterization of transposable elements) with population genomics (such as variant calling and analyses of hybridization), and simulation-based approaches. This Postdoc
-
for a PhD student in analytical chemistry to develop analytical methods for single cell analysis using direct infusion mass spectrometry. The PhD candidate will work with and develop custom made
-
position is available for a motivated student with experience in biostatistics, molecular epidemiology, biomedicine and large-scale computational analysis. The position is based in the research group led by
-
are announcing the position as DDLS PhD student in Data-driven precision medicine and diagnostics. Data-driven precision medicine and diagnostics covers data integration, analysis, visualization, and data
-
of organisms, and how these processes respond to environmental changes. Recent advancements in plant and animal physiology have been accelerated by the use of novel single-cell and tissue analysis techniques
-
the advertisement. Applications must be received at the last closing date at midnight, CET/CEST (Central European Time/Central European Summer Time). Applications must include the following elements: CV including
-
data analysis, programming, and biology. You will be part of a collaborative research team with deep experimental and analytical expertise, with access to advanced tumor models and state-of-the-art